Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like...
23 insider purchases on record · latest filing 2025-05-20.
Insiders have also filed 40 sale transactions at AURA.